托法替尼在溃疡性结肠炎合并坏疽性脓皮病患者中的治疗作用。
Tofacitinib, a useful option for the treatment of pyoderma gangrenosum in an ulcerative colitis patient.
机构信息
Aparato Digestivo, Complejo Hospitalario de Navarra, España.
Aparato Digestivo, Complejo Hospitalario de Navarra.
出版信息
Rev Esp Enferm Dig. 2021 Oct;113(10):733-734. doi: 10.17235/reed.2021.7977/2021.
PMID:33845581
Abstract
Pyoderma gangrenosum (PG) is a difficult-to-manage ulcero-necrotizing dermatosis associated with inflammatory bowel disease (IBD). In this article, we report a refractory PG in a patient with severe ulcerative colitis (UC) that responded to tofacitinib 10 mg/12 h.
摘要
坏疽性脓皮病（PG）是一种难以治疗的溃疡性坏死性皮肤病，与炎症性肠病（IBD）有关。本文报道了一例严重溃疡性结肠炎（UC）患者出现难治性 PG，对托法替尼 10 mg/12 h 治疗有反应。
Zotero 插件